Guaranteed Healthcare

New Report Details Healthcare Industry’s Massive Spending in Presidential Campaign, Federal Lobbying - Findings Coincide with Release of “SiCKO” and Call For End to Insurance Interference with Nation’s Healthcare.  Massive spending by the healthcare industry is swamping the nation’s political process, according to the findings of a new report issued by the Institute for Health and Socio-Economic Policy (IHSP). The new report,  Market Based Healthcare: Big Money, Politics, and the Unraveling of U.S. Civil Democracy, coincides with the premiere of Michael Moore’s new documentary "SiCKO," a searing indictment of the U.S. healthcare system opening nationwide June 29.

 Download the new report here (2.87 MB)

 Download the new report here (2.87 MB)

Massive spending by the healthcare industry is swamping the nation’s political process, according to the findings of a new report issued today. It coincides with the premiere of Michael Moore’s new documentary "SiCKO," a searing indictment of the U.S. healthcare system which opens nationwide June 29.

The research was conducted by the California Nurses Association/National Nurses Organizing Committee’s research arm, the Institute for Health and Socio-Economic Policy, based on a comprehensive analysis of publicly available and custom data sets from the Center for Responsive Politics.

CNA/NNOC released the report today as Moore joined nurses and doctors from around the U.S. in a New Hampshire town hall meeting on healthcare with undecided voters. "SiCKO" describes the heartbreaking, systemic denial of care by healthcare industry giants, and links it to escalating profits and the industry’s hefty clout in Congress.

"These staggering sums have a crushing impact on policy and are drowning out the voices of patients and other ordinary Americans who can’t begin to match the financial clout of the big drug companies, insurers, and other healthcare industry giants," said CNA/NNOC President Deborah Burger, RN.

The avalanche of cash has a direct impact on healthcare policy in Washington and influences positions on healthcare reform taken by candidates for public office, asserts CNA/NNOC.
 
"That political influence produces huge financial benefits for the healthcare industry," Burger noted. They include blocking bills to protect patients from HMO, hospital, or nursing home abuses, provide greater public oversight of insurers, or permit the re-importation of cheaper prescription medications from Canada or Europe.

Additionally, most healthcare "reform" proposals directly benefit the biggest political spenders, from the insurers to the drug companies to the commercial banks and investment firms now promoting Health Savings Accounts and tax-credits to buy insurance.

In federal lobbying alone, healthcare spending exceeded $2.2 billion the past decade, during which healthcare surpassed all other industry sectors in lobbying expenditures.

Healthcare industry contributions have also become a significant factor in the 2008 presidential contest as well, according to the report.

Political action committees for drug and insurance companies, doctors, hospitals, dentists, and nursing homes are lavishing millions of dollars on both Democratic and Republican candidates, the report found. Democratic Sen. Hillary Clinton and Republican Sen. John McCain together received over 40% of healthcare industry contributions among the 18 major party declared candidates.

Overall, healthcare contributions to the 18 currently announced Republican and Democratic presidential candidates total an aggregate $12.8 million since 1989, over $3.7 million of that amount just in the first quarter of 2007 alone.

"No wonder that in the midst of an escalating healthcare crisis, most of the candidates are unwilling to confront the corporate giants and support reform that takes profiteering out of our healthcare system," Burger said.

A breakdown by industry shows that former Massachusetts Gov. Mitt Romney is the top recipient of pharmaceutical contributions and money from banks and securities and investment firms which are becoming increasingly powerful players in healthcare and political contributions, especially with the rapid growth of Health Savings Accounts and other reform plans that rely on financial institutions. HSAs are typically linked to high deductible health plans, and are a main feature of the Massachusetts health plan that Romney promoted while governor.

Sen. Christopher Dodd, whose home state houses corporate offices for many insurance corporations, is the top beneficiary of insurance and HMO donations. Clinton leads among donations from health professionals and lobbyists.

In Congress, the huge sums spent on lobbying have paid huge dividends for the healthcare industry, Burger noted. One example is the April 2007 vote in the Senate, after heavy lobbying by the pharmaceutical and insurance industry, to kill a bill to amend the 2003 Medicare drug benefit law to let Medicare use its bulk purchasing power to negotiate lower prescription drug prices for seniors.

During the debate on the original bill, pharmaceutical and insurance companies spent so much that they could hire a different firm to lobby each key member of a critical committee (New York Times, Aug., 2005). Not surprisingly, the final bill requires seniors to go through private insurers to qualify for the drug benefit and barred the government from bargaining discounted prices.

As a result, drug prices in the U.S. continue to be 35% or more higher than in other Western nations. "Every day nurses see the consequences," said Burger. "We see families who share prescriptions so none of them get their needed dosage, and individuals who cut pills in half or run out of pills before the end of the month, ask the physician to prescribe a less effective generic drug or, worst of all, simply never fill the prescription due to its cost."

Among other data in the report:

Scores of former government employees now work as healthcare industry lobbyists. One of the best known, as portrayed in "SiCKO," is Wilbert "Billy" Tauzin, a chief architect of the Medicare prescription drug bill who then gave up his seat in Congress to become the director of the Pharmaceutical Research and Manufactures of America (PhRMA), the drug industry’s chief lobbying group.

Escalating political spending coincides with huge jumps in healthcare industry profits. From 2002 to 2006, pharmaceutical profits climbed from $64.4 billion to $94.8 billion, and insurance profits from $20.8 billion in 2002 to $57.5 billion.

Financial firms have become an increasingly bigger player in healthcare and in political contributions. Nearly 1,100 banks now offer Health Savings Accounts, triple the number from 2005 and some big insurers, like Blue Cross/Blue Shield and UnitedHealth are chartering their own banks to get into the new lucrative market. The finance industry ranks third, behind healthcare and communications/technology, in lobbying expenditures.

More families are struggling with huge medical bills and debt. One-fifth of working age adults currently have medical debt, and one-quarter of adults spend 10% or more of their household income annually on out-of-pocket medical expenses and premiums. 

Burger noted the comment of PhRMA senior vice president Ken Johnson who said after a screening of "SiCKO" in Sacramento California last week, "Companies have to have an incentive. Otherwise, who's going to do it?" (Sacramento Bee, June 13, 2007)

In fact, "there is an alternative that is universal, comprehensive, assures choice of hospital and physician, controls costs, and gets the insurance companies out of the way," Burger noted.

HR 676 in Congress would establish a single-payer, publicly financed system that works as an expanded and improved Medicare for all. Similar bills exist in several states, such as SB 840 in California. "It's the only solution to our healthcare crisis that also would go a long way to stopping the corruption of our political system by the healthcare industry as well," said Burger.

 Download the new report here (2.87 MB)